NDC 51079-879-01
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51079-879
- Requested NDC
- 51079-879-01
- Package NDCs from labels
- 51079-879-01
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51079-879-01 | EA - Each | 51079-879 | cd6a3392-9a90-4721-a101-2378cd7f1cce | 1 | 2012-07-24 |
| 51079-879-20 | EA - Each | 51079-879 | 06e385d4-a2bf-444f-8d8c-307162edfe34 | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Polyethylene Glycol (3350) | POLYETHYLENE GLYCOL (3350) | Mylan Institutional Inc. | 219bcbc4-b84a-4209-9f34-ef2b0ef0d273 | 2026-04-08 | Warnings | Mylan Institutional Inc. |
| Chlorthalidone | CHLORTHALIDONE | Mylan Institutional Inc. | 193c85ba-43c2-4be2-82cf-7b394a83390e | 2026-01-20 | Warnings, Adverse reactions | Mylan Institutional Inc. |
| Levetiracetam | LEVETIRACETAM | Mylan Institutional Inc. | 08e1bfea-7f3f-42d9-823d-f75080e664ff | 2025-11-12 | Warnings, Adverse reactions | Mylan Institutional Inc. |
| Chlordiazepoxide Hydrochloride | CHLORDIAZEPOXIDE HYDROCHLORIDE | Mylan Institutional Inc. | 68c7d8a7-08b3-4a1a-acbd-09bbe67b8d4a | 2025-11-11 | Boxed warning, Warnings, Adverse reactions | Mylan Institutional Inc. |
| Clozapine | CLOZAPINE | Mylan Institutional Inc. | d5c8a456-6f3c-4963-b321-4ed746f690e4 | 2025-11-11 | Boxed warning, Warnings, Adverse reactions | Mylan Institutional Inc. |
| Thioridazine Hydrochloride | THIORIDAZINE HYDROCHLORIDE | Mylan Institutional Inc. | 52fea941-0b47-41c1-b00d-f88150e8ab93 | 2025-11-11 | Boxed warning, Warnings, Adverse reactions | Mylan Institutional Inc. |
| Divalproex Sodium | DIVALPROEX SODIUM | Mylan Institutional Inc. | b367d81d-4eca-4e28-b490-34be4c003561 | 2025-11-11 | Boxed warning, Warnings, Adverse reactions | Mylan Institutional Inc. |
| Lansoprazole | LANSOPRAZOLE | Mylan Institutional Inc. | eea82d0b-6600-4693-a2b8-596a55458f61 | 2025-11-11 | Warnings, Adverse reactions | Mylan Institutional Inc. |
| Haloperidol | HALOPERIDOL | Mylan Institutional Inc. | ad7d2f17-a4e8-4ebc-9baf-5983ac626782 | 2025-09-02 | Boxed warning, Warnings, Adverse reactions | Mylan Institutional Inc. |
| Fenofibrate | FENOFIBRATE | Mylan Institutional Inc. | 5a90e0a4-7892-462f-9776-037d23a93b10 | 2025-07-25 | Warnings, Adverse reactions | Mylan Institutional Inc. |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Mylan Institutional Inc. | cd69c192-cd3f-47e6-b0a6-c536ffed5c4b | 2025-07-23 | Boxed warning, Warnings, Adverse reactions | Mylan Institutional Inc. |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Mylan Institutional Inc. | 493a8b7e-5bb1-4db2-91a7-77ed87864131 | 2025-07-22 | Warnings, Adverse reactions | Mylan Institutional Inc. |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Mylan Institutional Inc. | 5723c7a7-2a1d-4ab6-bf39-b2165ae781a6 | 2025-07-22 | Boxed warning, Warnings, Adverse reactions | Mylan Institutional Inc. |
| Loratadine | LORATADINE | Mylan Institutional Inc. | 1fc9ddd1-393d-4fe2-a9e0-d192df7331db | 2025-07-22 | Warnings | Mylan Institutional Inc. |
| Loperamide Hydrochloride | LOPERAMIDE HYDROCHLORIDE | Mylan Institutional Inc. | ad71d4ab-d293-47a2-8f3f-2c9f42d76e40 | 2025-07-22 | Boxed warning, Warnings, Adverse reactions | Mylan Institutional Inc. |
| Methotrexate | METHOTREXATE | Mylan Institutional Inc. | 8df0780e-0fbd-4ab8-80b0-7a5eaa08ec0a | 2025-07-22 | Boxed warning, Warnings, Adverse reactions | Mylan Institutional Inc. |
| Metolazone | METOLAZONE | Mylan Institutional Inc. | e5fe856e-7fd6-47fb-87f7-7c1c621f50a0 | 2025-07-22 | Warnings, Adverse reactions | Mylan Institutional Inc. |
| Metoclopramide | METOCLOPRAMIDE | Mylan Institutional Inc. | 447dbb34-7903-4e6a-be31-48a0b0e0d2f5 | 2025-07-22 | Boxed warning, Warnings, Adverse reactions | Mylan Institutional Inc. |
| Metoprolol Tartrate | METOPROLOL TARTRATE | Mylan Institutional Inc. | 961248d5-d53c-408d-8f8f-d31885054f96 | 2025-07-22 | Warnings, Adverse reactions | Mylan Institutional Inc. |
| Spironolactone | SPIRONOLACTONE | Mylan Institutional Inc. | 7e1a8152-941a-4aa4-bcb0-83c04905678f | 2025-07-22 | Warnings, Adverse reactions | Mylan Institutional Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.